Unbiased quantitation of alveolar type II to alveolar type i cell transdifferentiation during repair after lung injury in mice

Nicole L. Jansing, Jazalle McClendon, Peter M. Henson, Rubin M. Tuder, Dallas M. Hyde, Rachel L. Zemans

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The alveolar epithelium consists of squamous alveolar type (AT) I and cuboidal ATII cells. ATI cells cover 95-98% of the alveolar surface, thereby playing a critical role in barrier integrity, and are extremely thin, thus permitting efficient gas exchange. During lung injury, ATI cells die, resulting in increased epithelial permeability. ATII cells re-epithelialize the alveolar surface via proliferation and transdifferentiation into ATI cells. Transdifferentiation is characterized by down-regulation of ATII cell markers, upregulation of ATI cell markers, and cell spreading, resulting in a change in morphology from cuboidal to squamous, thus restoring normal alveolar architecture and function. The mechanisms underlying ATII to ATI cell transdifferentiation have not been well studied in vivo. A prerequisite for mechanistic investigation is a rigorous, unbiased method to quantitate this process. Here, we used SPCCreERT2;mTmG mice, in which ATII cells and their progeny express green fluorescent protein (GFP), and applied stereologic techniques to measure transdifferentiation during repair after injury induced by LPS. Transdifferentiation was quantitated as the percent of alveolar surface area covered by ATII-derived (GFP1) cells expressing ATI, but not ATII, cell markers. Using this methodology, the time course and magnitude of transdifferentiation during repair was determined. We found that ATI cell loss and epithelial permeability occurred by Day 4, and ATII to ATI cell transdifferentiation began by Day 7 and continued until Day 16. Notably, transdifferentiation and barrier restoration are temporally correlated. This methodology can be applied to investigate the molecular mechanisms underlying transdifferentiation, ultimately revealing novel therapeutic targets to accelerate repair after lung injury.

Original languageEnglish (US)
Pages (from-to)519-526
Number of pages8
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume57
Issue number5
DOIs
StatePublished - Nov 1 2017

Fingerprint

Cell Transdifferentiation
Alveolar Epithelial Cells
Lung Injury
Repair
Green Fluorescent Proteins
Restoration
Gases
Cells
Permeability

Keywords

  • Alveolar epithelium
  • Lung injury and repair
  • Transdifferentiation

ASJC Scopus subject areas

  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Clinical Biochemistry
  • Cell Biology

Cite this

Unbiased quantitation of alveolar type II to alveolar type i cell transdifferentiation during repair after lung injury in mice. / Jansing, Nicole L.; McClendon, Jazalle; Henson, Peter M.; Tuder, Rubin M.; Hyde, Dallas M.; Zemans, Rachel L.

In: American Journal of Respiratory Cell and Molecular Biology, Vol. 57, No. 5, 01.11.2017, p. 519-526.

Research output: Contribution to journalArticle

Jansing, Nicole L. ; McClendon, Jazalle ; Henson, Peter M. ; Tuder, Rubin M. ; Hyde, Dallas M. ; Zemans, Rachel L. / Unbiased quantitation of alveolar type II to alveolar type i cell transdifferentiation during repair after lung injury in mice. In: American Journal of Respiratory Cell and Molecular Biology. 2017 ; Vol. 57, No. 5. pp. 519-526.
@article{33da0f45fffd43de811df6f5b8b95c62,
title = "Unbiased quantitation of alveolar type II to alveolar type i cell transdifferentiation during repair after lung injury in mice",
abstract = "The alveolar epithelium consists of squamous alveolar type (AT) I and cuboidal ATII cells. ATI cells cover 95-98{\%} of the alveolar surface, thereby playing a critical role in barrier integrity, and are extremely thin, thus permitting efficient gas exchange. During lung injury, ATI cells die, resulting in increased epithelial permeability. ATII cells re-epithelialize the alveolar surface via proliferation and transdifferentiation into ATI cells. Transdifferentiation is characterized by down-regulation of ATII cell markers, upregulation of ATI cell markers, and cell spreading, resulting in a change in morphology from cuboidal to squamous, thus restoring normal alveolar architecture and function. The mechanisms underlying ATII to ATI cell transdifferentiation have not been well studied in vivo. A prerequisite for mechanistic investigation is a rigorous, unbiased method to quantitate this process. Here, we used SPCCreERT2;mTmG mice, in which ATII cells and their progeny express green fluorescent protein (GFP), and applied stereologic techniques to measure transdifferentiation during repair after injury induced by LPS. Transdifferentiation was quantitated as the percent of alveolar surface area covered by ATII-derived (GFP1) cells expressing ATI, but not ATII, cell markers. Using this methodology, the time course and magnitude of transdifferentiation during repair was determined. We found that ATI cell loss and epithelial permeability occurred by Day 4, and ATII to ATI cell transdifferentiation began by Day 7 and continued until Day 16. Notably, transdifferentiation and barrier restoration are temporally correlated. This methodology can be applied to investigate the molecular mechanisms underlying transdifferentiation, ultimately revealing novel therapeutic targets to accelerate repair after lung injury.",
keywords = "Alveolar epithelium, Lung injury and repair, Transdifferentiation",
author = "Jansing, {Nicole L.} and Jazalle McClendon and Henson, {Peter M.} and Tuder, {Rubin M.} and Hyde, {Dallas M.} and Zemans, {Rachel L.}",
year = "2017",
month = "11",
day = "1",
doi = "10.1165/rcmb.2017-0037MA",
language = "English (US)",
volume = "57",
pages = "519--526",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "5",

}

TY - JOUR

T1 - Unbiased quantitation of alveolar type II to alveolar type i cell transdifferentiation during repair after lung injury in mice

AU - Jansing, Nicole L.

AU - McClendon, Jazalle

AU - Henson, Peter M.

AU - Tuder, Rubin M.

AU - Hyde, Dallas M.

AU - Zemans, Rachel L.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - The alveolar epithelium consists of squamous alveolar type (AT) I and cuboidal ATII cells. ATI cells cover 95-98% of the alveolar surface, thereby playing a critical role in barrier integrity, and are extremely thin, thus permitting efficient gas exchange. During lung injury, ATI cells die, resulting in increased epithelial permeability. ATII cells re-epithelialize the alveolar surface via proliferation and transdifferentiation into ATI cells. Transdifferentiation is characterized by down-regulation of ATII cell markers, upregulation of ATI cell markers, and cell spreading, resulting in a change in morphology from cuboidal to squamous, thus restoring normal alveolar architecture and function. The mechanisms underlying ATII to ATI cell transdifferentiation have not been well studied in vivo. A prerequisite for mechanistic investigation is a rigorous, unbiased method to quantitate this process. Here, we used SPCCreERT2;mTmG mice, in which ATII cells and their progeny express green fluorescent protein (GFP), and applied stereologic techniques to measure transdifferentiation during repair after injury induced by LPS. Transdifferentiation was quantitated as the percent of alveolar surface area covered by ATII-derived (GFP1) cells expressing ATI, but not ATII, cell markers. Using this methodology, the time course and magnitude of transdifferentiation during repair was determined. We found that ATI cell loss and epithelial permeability occurred by Day 4, and ATII to ATI cell transdifferentiation began by Day 7 and continued until Day 16. Notably, transdifferentiation and barrier restoration are temporally correlated. This methodology can be applied to investigate the molecular mechanisms underlying transdifferentiation, ultimately revealing novel therapeutic targets to accelerate repair after lung injury.

AB - The alveolar epithelium consists of squamous alveolar type (AT) I and cuboidal ATII cells. ATI cells cover 95-98% of the alveolar surface, thereby playing a critical role in barrier integrity, and are extremely thin, thus permitting efficient gas exchange. During lung injury, ATI cells die, resulting in increased epithelial permeability. ATII cells re-epithelialize the alveolar surface via proliferation and transdifferentiation into ATI cells. Transdifferentiation is characterized by down-regulation of ATII cell markers, upregulation of ATI cell markers, and cell spreading, resulting in a change in morphology from cuboidal to squamous, thus restoring normal alveolar architecture and function. The mechanisms underlying ATII to ATI cell transdifferentiation have not been well studied in vivo. A prerequisite for mechanistic investigation is a rigorous, unbiased method to quantitate this process. Here, we used SPCCreERT2;mTmG mice, in which ATII cells and their progeny express green fluorescent protein (GFP), and applied stereologic techniques to measure transdifferentiation during repair after injury induced by LPS. Transdifferentiation was quantitated as the percent of alveolar surface area covered by ATII-derived (GFP1) cells expressing ATI, but not ATII, cell markers. Using this methodology, the time course and magnitude of transdifferentiation during repair was determined. We found that ATI cell loss and epithelial permeability occurred by Day 4, and ATII to ATI cell transdifferentiation began by Day 7 and continued until Day 16. Notably, transdifferentiation and barrier restoration are temporally correlated. This methodology can be applied to investigate the molecular mechanisms underlying transdifferentiation, ultimately revealing novel therapeutic targets to accelerate repair after lung injury.

KW - Alveolar epithelium

KW - Lung injury and repair

KW - Transdifferentiation

UR - http://www.scopus.com/inward/record.url?scp=85032722205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032722205&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2017-0037MA

DO - 10.1165/rcmb.2017-0037MA

M3 - Article

C2 - 28586241

AN - SCOPUS:85032722205

VL - 57

SP - 519

EP - 526

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 5

ER -